Im Cannabis Corp (TSE:IMCC) has released an update.
IM Cannabis Corp, a leading medical cannabis company, anticipates significant growth in the German market following the country’s recent legalization and regulatory changes that transform cannabis into a regular prescription medication. With a robust 180% growth in 2023 and a top position in sales per SKU in the German flower market, IMC is poised to leverage its comprehensive infrastructure and supply agreements to capitalize on the expanding market. The company’s commitment to sustainable and profitable growth is underpinned by its strategic focus on the German and Israeli markets, withdrawing from Canadian operations to concentrate on these key areas.
For further insights into TSE:IMCC stock, check out TipRanks’ Stock Analysis page.
